Tildrakizumab vs Warfarin

## Tildrakizumab vs Warfarin: Overview

This comparison examines the pharmacological differences between **Tildrakizumab** and **Warfarin**.

## Mechanism of Action

**Warfarin**: Inhibits vitamin K epoxide reductase complex.

## Pharmacokinetics

**Half-life**: Tildrakizumab — N/A; Warfarin — 20-60 hours.

## Chemical Properties

**Molecular Formula**: Tildrakizumab — N/A; Warfarin — C19H16O4.

**Molecular Weight**: Tildrakizumab — N/A; Warfarin — 308.3280 g/mol.

**Type**: Tildrakizumab — Antibody; Warfarin — Small molecule.